Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 1.00 |
| ▸ | CA1 | P00915 | 3/20 | 1.00 |
| ▸ | CA9 | Q16790 | 3/20 | 1.00 |
| ▸ | RAB9A | P51151 | 8/20 | 0.69 |
| ▸ | NPC1 | O15118 | 8/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | HPGD | P15428 | 5/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.69 |
| ▸ | GAA | P10253 | 2/20 | 0.67 |
| ▸ | GLA | P06280 | 1/20 | 0.67 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30449676 | 1.00 | CA12 (1.00) | CA12CA1CA9RAB9ANPC1 | |
| SCHEMBL8513693 | 0.89 | CA12 (0.81) | CA12CA1CA9RAB9ANPC1 | |
| SCHEMBL15747020 | 0.87 | CA12 (0.76) | CA12CA1CA9RAB9ANPC1 | |
| SCHEMBL22685138 | 0.87 | CA12 (0.76) | CA12CA1CA9RAB9ANPC1 | |
| SCHEMBL15607719 | 0.87 | CA12 (0.76) | CA12CA1CA9RAB9ANPC1 | |
| SCHEMBL7915781 | 0.86 | CA12 (0.75) | CA12CA1CA9RAB9ANPC1 | |
| SCHEMBL30862484 | 0.86 | CA12 (0.75) | CA12CA1CA9RAB9ANPC1 | |
| SCHEMBL119578 | 0.85 | RAB9A (0.78) | CA12CA1CA9RAB9ANPC1 | |
| SCHEMBL11232995 | 0.85 | CA12 (0.74) | CA12CA1CA9RAB9ANPC1 | |
| SCHEMBL19278118 | 0.85 | CA12 (0.74) | CA12CA1CA9RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119432113-A | Aza-hemicyanine dye and application thereof | 广西师范大学 | 2025-02-14 | — | — | CN | claimed |
| US-11852582-B2 | Automatic photocurrent spectrum measurement system based on fourier infrared spectrometer | EAST CHINA NORMAL UNIVERSITY (CN) | 2023-12-26 | — | — | US | claimed |
| CN-116242697-A | Uniaxial compression mechanical property testing method for battery electrode material particles | 北京理工大学 | 2023-06-09 | — | — | CN | claimed |
| US-20220381683-A1 | AUTOMATIC PHOTOCURRENT SPECTRUM MEASUREMENT SYSTEM BASED ON FOURIER INFRARED SPECTROMETER | EAST CHINA NORMAL UNIVERSITY (CN) | 2022-12-01 | — | — | US | claimed |
| EP-2771488-B1 | CARBONIC ANHYDRASE IX-RELATED MARKERS AND USE THEREOF | SIGNALCHEM LIFESCIENCES CORP (CA) | 2018-03-28 | — | — | EP | claimed |
| US-20140148400-A1 | CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY | METASIGNAL THERAPEUTICS INC. (CA) | 2014-05-29 | — | — | US | claimed |
| WO-2012070024-A1 | CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY | METASIGNAL THERAPEUTICS INC. (CA) | 2012-05-31 | — | — | WO | claimed |
| CN-120737184-A | NA-CATH modified peptide and application thereof in preparation of antibacterial drugs | 中国医学科学院医药生物技术研究所 | 2025-10-03 | — | — | CN | disclosed |
| US-20250305102-A1 | STEEL SHEET | NIPPON STEEL CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| EP-3603648-B1 | COMPLEX OF NUCLEIC ACID MEDICINE AND MULTIBRANCHED LIPID | SHIONOGI & CO (JP) | 2025-09-17 | — | — | EP | disclosed |
| US-12415835-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-16 | — | — | US | disclosed |
| US-12371428-B2 | Pyridone compounds and methods of use | EXELIXIS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| WO-2025109338-A1 | SALT FORMS OF A CHROMENE COMPOUND | Ontrack Therapeutics Limited (GB) | 2025-05-30 | — | — | WO | disclosed |
| US-20140148400-A1 | CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY | METASIGNAL THERAPEUTICS INC. (CA) | 2014-05-29 | — | — | US | disclosed |
| WO-2012070024-A1 | CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY | METASIGNAL THERAPEUTICS INC. (CA) | 2012-05-31 | — | — | WO | disclosed |
| WO-2012070024-A1 | CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY | METASIGNAL THERAPEUTICS INC. (CA) | 2012-05-31 | — | — | WO | disclosed |
| EP-1926757-B1 | ANTIBODY-COMB POLYMER CONJUGATE | UCB PHARMA SA (BE) | 2012-02-22 | — | — | EP | disclosed |
| CN-101712666-A | Preparation method of laser dye 7-amino-4-methylcoumarin | TIANJIN CHEM REAGENT RES INST | 2010-05-26 | — | — | CN | disclosed |
| EP-2014285-A1 | NPYY5 antagonists | Shionogi&Co., Ltd. (JP) | 2009-01-14 | — | — | EP | disclosed |
| US-20080138817-A1 | Novel Functional Peptide Nucleic Acid Monomer and Process for Producing the Same | CREDIA JAPAN CO., LTD. (JP) | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148400-A1 | CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY | CA7, CA4, CA2 | CA12 10/4885CA1 5/4885CA9 4/4885 |
| US-12371428-B2 | Pyridone compounds and methods of use | PDXK, PLK2, MAP4K2 | CA12 4882/4885CA1 4815/4885CA9 4885/4885 |
| US-20080138817-A1 | Novel Functional Peptide Nucleic Acid Monomer and Process for Producing the Same | NSUN3, RNGTT, NSUN2 | CA12 1995/4885CA1 3208/4885CA9 2364/4885 |
| US-12415835-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | CA12 1113/4885CA1 1024/4885CA9 1496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.